Cargando…
Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II
BACKGROUND: Annexin II heavy chain (also called p36, calpactin I) is lost in prostate cancers and in a majority of prostate intraepithelial neoplasia (PIN). Loss of annexin II heavy chain appears to be specific for prostate cancer since overexpression of annexin II is observed in a majority of human...
Autores principales: | Liu, Jie, Rothermund, Christy A, Ayala-Sanmartin, Jesus, Vishwanatha, Jamboor K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC200965/ https://www.ncbi.nlm.nih.gov/pubmed/12962548 http://dx.doi.org/10.1186/1471-2091-4-10 |
Ejemplares similares
-
Casodex treatment induces hypoxia-related gene expression in the LNCaP prostate cancer progression model
por: Rothermund, Christy A, et al.
Publicado: (2005) -
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines
por: Vishwanatha, Jamboor K, et al.
Publicado: (2004) -
Clinical Significance of Annexin A2 Expression in Breast Cancer Patients
por: Gibbs, Lee D., et al.
Publicado: (2020) -
Expression of biomarkers modulating prostate cancer angiogenesis: Differential expression of annexin II in prostate carcinomas from India and USA
por: Banerjee, Abhijit G, et al.
Publicado: (2003) -
SUMOylation regulates nucleo-cytoplasmic shuttling of Elk-1
por: Salinas, Sara, et al.
Publicado: (2004)